<ARTICLE> 5
<CIK> 0000904973
<NAME> GENZYME TRANSGENICS CORP
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-28-1997
<PERIOD-END>                               DEC-28-1997
<CASH>                                           6,383
<SECURITIES>                                         0
<RECEIVABLES>                                   10,907
<ALLOWANCES>                                     (390)
<INVENTORY>                                        678
<CURRENT-ASSETS>                                24,400
<PP&E>                                          32,906
<DEPRECIATION>                                 (6,609)
<TOTAL-ASSETS>                                  70,980
<CURRENT-LIABILITIES>                           32,823
<BONDS>                                          9,862
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           174
<OTHER-SE>                                      27,204
<TOTAL-LIABILITY-AND-EQUITY>                    70,980
<SALES>                                         62,938
<TOTAL-REVENUES>                                62,938
<CGS>                                           54,829
<TOTAL-COSTS>                                   71,290
<OTHER-EXPENSES>                                 (186)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,129
<INCOME-PRETAX>                                (9,295)
<INCOME-TAX>                                        48
<INCOME-CONTINUING>                            (9,343)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,343)
<EPS-PRIMARY>                                   (0.54)
<EPS-DILUTED>                                   (0.54)<F1>
<FN><F1> PER SHARE AMOUNTS HAVE BEEN RESTATED TO REFLECT ADOPTION OF SFAS 128. 
HOWEVER, DUE TO THE COMPANY'S NET LOSS FROM CONTINUING OPERATIONS AND NET LOSS
FOR THE 3 FISCAL YEARS TO THE PERIOD ENDED DEC. 28, 1997, EARNINGS PER SHARE 
HAVE NOT CHANGED AND, THEREFORE, RESTATED FINANCIAL DATA SCHEDULES WILL NOT BE 
SUBMITTED.
</FN>